Awards as PI
Program Type | Institution | Grant Title | Award Value |
---|---|---|---|
Disease Team Therapy Planning I | Stanford University | Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma | $109,750 |
Therapeutic Translational Research Projects | Stanford University | 2nd Generation Vaccine for the Treatment of Glioblastoma | $2,929,889 |
Discovery Research Projects | Stanford University | Identifying HLA Class I Restricted Peptides That Induce CD8+ T Cells Against SARS-CoV-2 | $249,999 |
Total: $3,289,638.00 |
Publications
- Sci Transl Med 2021 Enhancing proteasomal processing improves survival for a peptide vaccine used to treat glioblastoma. (PubMed: 34135109)